Residue 315 regulates V3 exposure and V3 antibody recognition on HIV subtype B and C viruses by Manhas S, Clark B, Gorny MK, Zolla-Pazner S, Pantophlet R

Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses by Gorny MK, Robinson J, Tuen M, Visciano ML, Hioe CE

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection by Gorny MK, Vanham G, Heyndrickx L, Williams C, Burda S, Nyambi PN

High-resolution crystal structure of the Fv of quaternary neutralizing epitope mAb 2909 reveals atomic details of its antigen-binding site by Sampson JM, Killikelly A, Zhang H, Gorny MK, Zolla-Pazner S, Kong X

P04-42. Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crown by Zollla-Pazner S, Gorny MK, Williams C, Sampson J, Totrov M, Jiang X, Kong X

Biophysical dissection of the antigen-antibody interaction of the broadly reactive anti-V3 human mAb 447-52D by Killikelly A, Zhang H, Spurrier B, Williams C, Gorny MK, Zolla-Pazner S, Kong X

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope by Wang S, Seaman MS, Krachmarov C, Pinter A, Totrov M, Gorny MK, Jiang X, Cohen S, Hioe C, Cardozo T, Kong X, Zolla-Pazner S, Lu S